Author Index: D

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
de Bekker-Grob, E. W.
• DISCRETE CHOICE EXPERIMENT AS A TOOL TO CHANGE MEDICAL PRACTICE EFFICIENTLY: AN APPLICATION TO BASAL CELL CARCINOMA FOLLOW-UP VISITS

• CLOSING CEREMONY AND AWARD PRESENTATIONS
de Haes, J. C.
• DISCLOSING THE UNCERTAINTY OF PROGNOSTIC ESTIMATES IN BREAST CANCER: CURRENT PRACTICES AND PATIENTS' AWARENESS OF UNCERTAINTY
de Vries, E.
• DISCRETE CHOICE EXPERIMENT AS A TOOL TO CHANGE MEDICAL PRACTICE EFFICIENTLY: AN APPLICATION TO BASAL CELL CARCINOMA FOLLOW-UP VISITS
de Vries, M.
• DEVELOPMENT OF HEALTH-RELATED QUALITY OF LIFE FOLLOWING PROSTATE CANCER DIAGNOSIS IS ASSOCIATED WITH OPTIMISM AND SELF-EFFICACY

• ORAL ABSTRACTS: PATIENT DECISION MAKING & DECISION AIDS

• SMDM CORE COURSE: INTRODUCTION TO THE PSYCHOLOGY OF MEDICAL DECISION MAKING

• SMDM CORE COURSE: INTRODUCTION TO SHARED DECISION MAKING AND PATIENT DECISION AIDS
de Wit, A.
• ASSESSING CVD RISK AND BURDEN: DIFFERENCES IN PREDICTION MODELS AND POPULATIONS

• THE COST OF BEING WRONG: THE IMPACT OF PREDICTION UNCERTAINTY ON THE COST-EFFECTIVENESS OF RISK-STRATIFIED STRATEGIES

• FROM PREDICTED RISK TO PREDICTED BURDEN OF CARDIOVASCULAR DISEASE

• RETHINKING METHODS TO IDENTIFY OPTIMAL TREATMENT AND DIAGNOSTIC THRESHOLDS: EVALUATING RISK-BASED OUTCOMES IN CORONARY HEART DISEASE
Degtyarev, E.
• ASSOCIATION OF DISEASE PROGRESSION, HEALTH-RELATED QUALITY OF LIFE, AND UTILITY IN PATIENTS WITH ADVANCED, NONFUNCTIONAL, WELL-DIFFERENTIATED GASTROINTESTINAL OR LUNG NEUROENDOCRINE TUMORS IN THE PHASE 3 RADIANT-4 TRIAL
Dehmel, B.
• MODELLING ETELCALCETIDE EFFECTIVENESS ON HEALTH OUTCOMES: RELATING BIOCHEMICAL OUTCOMES TO MORTALITY, CARDIOVASCULAR EVENTS, FRACTURES AND PARATHYROIDECTOMY
Dekker, E.
• RESILIENCE OF A FAECAL IMMUNOCHEMICAL TEST SCREENING PROGRAMME AGAINST SCREENING FATIGUE
Dekker, R.
• THE MOST EFFICIENT CRITICAL VACCINATION COVERAGE AND ITS EQUIVALENCE WITH MAXIMIZING THE HERD EFFECT

• DOSE-OPTIMAL VACCINE ALLOCATION OVER MULTIPLE POPULATIONS
Delaney, B.
• ORAL ABSTRACTS: CHD, CVD AND CANCER

• NUMERACY INFLUENCES PHYSICIANS' RISK COMMUNICATION ABOUT CANCER SCREENING
Dias, S.
• SENSITIVITY OF TREATMENT DECISIONS TO BIAS ADJUSTMENT IN NETWORK META-ANALYSIS
Diederich, A.
• SYMPOSIUM: VACCINE DECISION MAKING - FINDING EFFECTIVE WAYS TO INCREASE VACCINE UPTAKE
Dietz, B.
• LONG-TERM EFFECTIVENESS AND COST EFFECTIVENESS OF DIFFERENT ANTIVIRAL TREATMENTS FOR CHRONIC GENOTYPE-1 HCV INFECTION IN GERMANY INCLUDING OMBITASVIR/PARITAPREVIR/RITONAVIR AND DASABUVIR
Díez, F. J.
• COST-EFFECTIVENESS OF COLORECTAL CANCER SCREENING IN ARAGON (SPAIN)

• AN EMPIRICAL COMPARISON OF THREE VERSIONS OF THE TIME TRADE-OFF
Dobler, C. C.
• COMMUNICATING RISKS AND BENEFITS OF PREVENTIVE TUBERCULOSIS TREATMENT: AUSTRALIAN PHYSICIANS' PERSPECTIVES
Dodd, P.
• CONTINGENCY MANAGEMENT IMPROVES COMPLETION OF HEPATITIS B VACCINATION IN THOSE ON TREATMENT FOR OPIATE DEPENDENCE: AN ECONOMIC EVALUATION
Dorr, M. B.
• BEZLOTOXUMAB IS ASSOCIATED WITH A REDUCTION IN CUMULATIVE HOSPITALIZED DAYS: ANALYSIS OF THE HOSPITALIZATION DATA FROM THE MODIFY I AND II CLINICAL TRIALS

• COST-EFFECTIVENESS OF BEZLOTOXUMAB+STANDARD OF CARE (SOC) VERSUS PLACEBO+SOC FOR THE PREVENTION OF RECURRENT CLOSTRIDIUM DIFFICILE INFECTION IN THE UNITED STATES
Douthwaite, S.
• A RAPID INFLUENZA TEST IN HOSPITALS COULD AVOID UNNECESSARY PAEDIATRIC ISOLATION BED DAYS AND SAVE COSTS

• ESTIMATING THE CLINICAL IMPACT AND COSTS OF IMPLEMENTING A POINT OF CARE TEST FOR INFLUENZA A/B AND RESPIRATORY SYNCYTIAL VIRUS ON AN ACUTE PAEDIATRIC HOSPITAL INPATIENT WARD
Dowie, J.
• A COMPARISON OF PATIENTS' AND HEALTHCARE PROFESSIONALS' PREFERENCES FOR THE CHARACTERISTICS OF DISEASE MODIFYING DRUGS IN DECISION MAKING ABOUT MULTIPLE SCLEROSIS TREATMENT
Dowie, J.
• THRESHOLD-BASED GUIDELINES THREATEN PREFERENCE-SENSITIVE DECISION MAKING IN PERSON-CENTRED CARE

• PRODUCING QUALITY-ADJUSTED OPINIONS FOR PREFERENCE-SENSITIVE MULTI-CRITERIAL DECISION SUPPORT
Downs, S. M.
• ENVISIONING A REAL OR IMAGINARY DEPENDENT: IMPACT ON UTILITY ASSESSMENT
Dubberke, E.
• COST-EFFECTIVENESS OF BEZLOTOXUMAB+STANDARD OF CARE (SOC) VERSUS PLACEBO+SOC FOR THE PREVENTION OF RECURRENT CLOSTRIDIUM DIFFICILE INFECTION IN THE UNITED STATES
Duggan, M.
• PREDICTORS OF PATIENT PREFERENCES FOR WHOLE BODY MAGNETIC RESONANCE IMAGING COMPARED WITH STANDARD STAGING PATHWAYS FOR THE INVESTIGATION OF SYMPTOMS OF SUSPECTED COLORECTAL OR LUNG CANCER
Duguet, A.
• DIRECT ANTIVIRAL DRUGS FOR THE TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH GENOTYPE 1 OR 4 IN FRANCE - COST-EFFECTIVENESS OF OMBITASVIR/PARITAPREVIR/RITONAVIR WITH OR WITHOUT DASABUVIR BY FIBROSIS SUBGROUP

• BUDGET IMPACT ANALYSIS INCLUDING OMBITASVIR/PARITAPREVIR/RITONAVIR AND DASABUVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C IN FRANCE
Duijzer, E.
• THE MOST EFFICIENT CRITICAL VACCINATION COVERAGE AND ITS EQUIVALENCE WITH MAXIMIZING THE HERD EFFECT

• DOSE-OPTIMAL VACCINE ALLOCATION OVER MULTIPLE POPULATIONS
Durand-Zaleski, I.
• DIRECT ANTIVIRAL DRUGS FOR THE TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH GENOTYPE 1 OR 4 IN FRANCE - COST-EFFECTIVENESS OF OMBITASVIR/PARITAPREVIR/RITONAVIR WITH OR WITHOUT DASABUVIR BY FIBROSIS SUBGROUP
Dwyer, C.
• DOES MEDICAL EDUCATION PROVIDE A SHARED UNDERSTANDING OF THE TREATMENT THRESHOLD PROBABILITY FOR SUSPECTED STREP THROAT?
Dzowela, T.
• THE USE OF SPECIALTY TRAINING TO RETAIN DOCTORS IN MALAWI: A DISCRETE CHOICE EXPERIMENT
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z